Bicara Therapeutics Inc. (BCAX)

Typically moves ±5.82% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-11 ESTIMATED

Since Nov 12, 2024, Bicara Therapeutics Inc. (BCAX) has reported earnings 8 times. On average the shares move ±5.82% post-earnings, with a positive reaction 50.0% of the time. Its largest post-earnings gain was +4.8% (Aug 12, 2025) and its largest decline was -14.11% (Aug 11, 2026). The next earnings report is predicted for 2026-11-11 (estimated).

Earnings reactions

How BCAX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.82%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 11, 2026	☀ PRE	-14.11%	open_in_new
May 11, 2026	☀ PRE	+1.49%	open_in_new
Mar 30, 2026	☀ PRE	+3.65%	open_in_new
Nov 10, 2025	☀ PRE	-4.85%	open_in_new
Aug 12, 2025	☀ PRE	+4.8%	open_in_new
May 13, 2025	☀ PRE	-8.1%	open_in_new
Mar 27, 2025	☀ PRE	+2.29%	open_in_new
Nov 12, 2024	☀ PRE	-7.3%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.82%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 25 →

Funds holding

$397071048

Total value held

Buying

20 added · 5 reduced

Blackrock, Inc.

$114249784 +35.32%

Janus Henderson Group Plc

$66350262 NEW BUY

State Street Corp

$60832435 +44.35%

Franklin Resources Inc

$57951672 +20.37%

Jpmorgan Chase & Co

$29808414 +472.67%

SEC Filing Types

description SCHEDULE 13G/A

13 chevron_right

description SCHEDULE 13G

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
144	20260908	open_in_new SEC.gov
144	20260908	open_in_new SEC.gov
8-K	20260825	open_in_new SEC.gov
3	20260814	open_in_new SEC.gov
4	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260813	open_in_new SEC.gov
4	20260812	open_in_new SEC.gov
4	20260812	open_in_new SEC.gov
4	20260812	open_in_new SEC.gov
10-Q	20260811	open_in_new SEC.gov

Frequently asked about BCAX earnings

When does Bicara Therapeutics Inc. report earnings next? expand_more

Bicara Therapeutics Inc. (BCAX)'s next earnings date is estimated for 2026-11-11. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does BCAX stock move after earnings? expand_more

Over 8 reports, BCAX has moved an average of ±5.82% the session after earnings, closing higher 50.0% of the time.

What was BCAX's biggest post-earnings move? expand_more

BCAX's largest post-earnings gain on record was +4.8% on Aug 12, 2025, and its largest decline was -14.11% on Aug 11, 2026.

Where can I find Bicara Therapeutics Inc.'s SEC filings? expand_more

All of Bicara Therapeutics Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.